Table 1.
MBP, EDN and ECP serum concentrations in patients with BP at the time of diagnosis according to either the extent (A) or the outcome of the disease (B).
| A | |||
|---|---|---|---|
| Disease extent | Moderate (n = 24) | Extensive (n = 19) | P value |
| Protein concentration (ng/mL) | |||
| MBP | 2722 (±3362) | 4573 (±5142) | 0.44 |
| EDN | 327 (±181) | 332 (±159) | 0.62 |
| ECP | 90 (±117) | 52 (±45) | 0.82 |
| B | |||
| Disease outcome | Remission (n = 26) | Relapse (n = 17) | P value |
| Protein concentration (ng/mL) | |||
| MBP | 3250 (±4092) | 3983(±4664) | 0.51 |
| EDN | 336 (±193) | 319 (±130) | 0.86 |
| ECP | 85 (±114) | 56 (±49) | 0.91 |
Extensive disease was defined as more than 10 new blisters daily. Relapse was defined as the reappearance of at least 3 new daily blisters in between one year follow-up. No statistically significant difference was observed using Mann Whitney test.